The pathobiology of the osteoclast.

This article reviews recent information concerning the origin of osteoclasts and the local and systemic regulation of their activity. It appears that much of the environmental responsiveness of osteoclasts is mediated by cells of the osteoblastic lineage, which exert a major influence on the localisation, induction, stimulation, and inhibition of osteoclastic bone resorption. Some of the mechanisms by which osteoclast function may be disturbed by inflammatory and neoplastic diseases are discussed, and it is suggested that many pathological disturbances of osteoclastic bone resorption may be explicable as mimicry of physiological regulatory mechanisms by local hormones introduced into bone as the local regulators of the diseased tissue.

[1]  A. F. Stewart,et al.  Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. , 1980, The New England journal of medicine.

[2]  T. Powles,et al.  BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRIN , 1976, The Lancet.

[3]  J. Puzas,et al.  Parathyroid hormone stimulation of collagenase secretion by isolated bone cells. , 1979, Endocrinology.

[4]  E Bell,et al.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Meunier,et al.  Quantitative histology of myeloma‐induced bone changes , 1982, British journal of haematology.

[6]  G. Mundy,et al.  Direct resorption of bone by human breast cancer cells in vitro , 1978, Nature.

[7]  A. Tashjian,et al.  Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. , 1973, Prostaglandins.

[8]  T. Martin,et al.  Activation of adenosine 3',5'-monophosphate-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2, and prostacyclin. , 1981, Endocrinology.

[9]  D. Klein,et al.  Prostaglandins: stimulation of bone resorption in tissue culture. , 1970, Endocrinology.

[10]  H. Heath,et al.  Calcitonin: physiology and pathophysiology. , 1981, The New England journal of medicine.

[11]  Z. Jaworski,et al.  Kinetics of osteoclasts and their nuclei in evolving secondary Haversian systems. , 1981, Journal of anatomy.

[12]  J. Oates,et al.  Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. , 1975, The New England journal of medicine.

[13]  G. W. Bernard,et al.  Osteoclast formation in vitro from bone marrow mononuclear cells in osteoclast-free bone. , 1981, The American journal of anatomy.

[14]  J. Bergeron,et al.  Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat , 1980, The Journal of cell biology.

[15]  V. Raina Normal osteoid tissue , 1972, Journal of clinical pathology.

[16]  S. Marks,et al.  CHAPTER 6 – Mammalian Osteopetrosis—A Model for Studying Cellular and Humoral Factors in Bone Resorption , 1976 .

[17]  M. Wills,et al.  Prostaglandins, bone resorption and hypercalcemia. , 1973, The New England journal of medicine.

[18]  C. Andrew L. Bassett,et al.  Generation of Electric Potentials by Bone in Response to Mechanical Stress , 1962, Science.

[19]  C. Galasko Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.

[20]  W. Sturtridge,et al.  Immunohistochemical demonstration of calcitonin binding to specific cell types in fixed rat bone tissue. , 1981, Endocrinology.

[21]  N. Athanasou,et al.  Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts. , 1984, The Journal of endocrinology.

[22]  J. Reynolds,et al.  Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. , 1984, Biochimica et biophysica acta.

[23]  S. Rushton,et al.  The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour‐mediated osteolysis , 1980, The British journal of surgery.

[24]  J. Harrelson,et al.  Newer knowledge of vitamin D and its metabolites in health and disease. , 1979, Clinical orthopaedics and related research.

[25]  J. Reynolds,et al.  A factor synthesized by rabbit periosteal fibroblasts stimulates bone resorption and collagenase production by connective tissue cells in vitro. , 1984, Biochimica et biophysica acta.

[26]  S. Marx,et al.  Calcitonin Receptors of Kidney and Bone , 1972, Science.

[27]  R. Baron,et al.  Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. , 1982, The Journal of clinical endocrinology and metabolism.

[28]  S. Teitelbaum,et al.  Multinucleation enhances macrophage-mediated bone resorption. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[29]  S. Marks,et al.  The origin of osteoclasts: evidence, clinical implications and investigative challenges of an extra-skeletal source. , 1983, Journal of oral pathology.

[30]  S. Mergenhagen,et al.  Macrophage-lymphocyte synergy in the production of osteoclast activating factor. , 1974, Journal of immunology.

[31]  I Binderman,et al.  Bone remodelling induced by physical stress is prostaglandin E2 mediated. , 1980, Biochimica et biophysica acta.

[32]  F. Singer,et al.  Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy. , 1981, The Journal of clinical endocrinology and metabolism.

[33]  B. Thomson,et al.  The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. , 1985, Endocrinology.

[34]  S. Miller,et al.  Morphological and ultrastructural aspects of the activation of avian medullary bone osteoclasts by parathyroid hormone , 1984, The Anatomical record.

[35]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture , 1972, Science.

[36]  G. Mundy,et al.  Evidence for the secretion of an osteoclast stimulating factor in myeloma. , 1974, The New England journal of medicine.

[37]  G. Mundy,et al.  Association of increased cyclic adenosine 3':5'-monophosphate content in cultured human breast cancer cells and release of hydrolytic enzymes and bone-resorbing activity. , 1983, Cancer research.

[38]  R. Jilka,et al.  Homologous and Heterologous Control of Bone Cell Adenosine 3′,5′-Monophosphate Response to Hormones by Parathormone, Prostaglandin E2, Calcitonin, and 1,25-hydroxycholecalciferol* , 1980 .

[39]  B. Thomson,et al.  Effect of substrate composition on bone resorption by rabbit osteoclasts. , 1984, Journal of cell science.

[40]  L. Avioli,et al.  The vitamin D family revisited. , 1984, The New England journal of medicine.

[41]  F. Murad,et al.  Effect of thyrocalcitonin on adenosine 3':5'-cyclic phosphate formation by rat kidney and bone. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Chambers,et al.  Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6‐oxo‐E1 , 1983, The Journal of pathology.

[43]  C. Galasko,et al.  Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins , 1976, Nature.

[44]  J. P. Scherft The lamina limitans of the organic matrix of calcified cartilage and bone. , 1972, Journal of ultrastructure research.

[45]  L. Raisz Stimulation of Bone Resorption by Parathyroid Hormone in Tissue Culture , 1963, Nature.

[46]  A. C. Allison,et al.  Membrane fusion reaction: a theory. , 1971, Journal of theoretical biology.

[47]  T. Martin,et al.  Activity ratio measurements reflect intracellular activation of adenosine 3',5'-monophosphate-dependent protein kinase in osteoblasts. , 1982, Endocrinology.

[48]  J. Loutit,et al.  RESORPTION OF BONE , 1979, The Lancet.

[49]  M. Kaye When is it an osteoclast? , 1984, Journal of clinical pathology.

[50]  Riley Lh,et al.  Skeletal changes during prolonged external irradiation: alterations in marrow, growth plate and osteoclast populations. , 1979 .

[51]  A. Jones,et al.  Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization , 1982, The Journal of cell biology.

[52]  A. Tashjian Role of prostaglandins in the production of hypercalcemia by tumors. , 1978, Cancer research.

[53]  S. Miller,et al.  Bone cells in culture: morphologic transformation by hormones. , 1976, Science.

[54]  T. Powles,et al.  Failure of indomethacin to reduce hydroxyproline excretion or hypercalcemia in patients with breast cancer , 1976 .

[55]  T. Chambers,et al.  The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. , 1983, The Journal of clinical endocrinology and metabolism.

[56]  P. Reitsma,et al.  Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Alkon,et al.  Calcium and cAMP as Synarchic Messengers , 1983 .

[58]  R. Baron,et al.  Behavior of osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats , 1981 .

[59]  D. Hume,et al.  The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80 , 1985 .

[60]  E. Bonucci New knowledge on the origin, function and fate of osteoclasts. , 1981, Clinical orthopaedics and related research.

[61]  C. Galasko The pathological basis for skeletal scintigraphy. , 1972, The Journal of bone and joint surgery. British volume.

[62]  R. Jilka,et al.  A collagenolytic response to parathormone, 1,25-dihydroxycholecalciferol D3, and prostaglandin E2 in bone of osteopetrotic (mi/mi) mice. , 1983, Endocrinology.

[63]  T. Chambers,et al.  Phagocytosis and trypsin‐resistant glass adhesion by osteoclasts in culture , 1979, The Journal of pathology.

[64]  V. Perry,et al.  The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. , 1984, The Anatomical record.

[65]  J. Loutit,et al.  Longevity of osteoclasts in radiation chimaeras of osteopetrotic beige and normal mice. , 1982, British journal of experimental pathology.

[66]  S. Marks,et al.  Transformations of osteoclast phenotype in ia rats cured of congenital osteopetrosis , 1982, Journal of morphology.

[67]  N. Finlayson,et al.  The Growth of Brown-Pearce Carcinoma in the Medullary Cavity of the Rabbit Femur , 1963, British Journal of Cancer.

[68]  S. Tsao,et al.  Some mechanisms of local bone destruction by squamous carcinomas of the head and neck. , 1981, British Journal of Cancer.

[69]  T. Chambers,et al.  Calcitonin alters behaviour of isolated osteoclasts , 1982, The Journal of pathology.

[70]  E H Burger,et al.  In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes , 1982, The Journal of experimental medicine.

[71]  G. Mundy,et al.  Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor. , 1981, The Journal of clinical investigation.

[72]  D. Gingell Computed surface potential changes with membrane interaction. , 1968, Journal of theoretical biology.

[73]  P. Gaillard Parathyroid gland and bone in vitro. , 1957, Schweizerische medizinische Wochenschrift.

[74]  S. Ralston,et al.  HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK? , 1982, The Lancet.

[75]  M. Wills,et al.  Prostaglandin Production and Bone Resorption by Dental Cysts , 1973, Nature.

[76]  F. Singer,et al.  ACUTE EFFECTS OF CALCITONIN ON OSTEOCLASTS IN MAN , 1976, Clinical endocrinology.

[77]  A. Badger,et al.  Isolation of a bone-resorptive factor from human cancer ascites fluid. , 1978, Cancer research.

[78]  W. E. Roberts Cell population dynamics of periodontal ligament stimulated with parathyroid extract. , 1975, The American journal of anatomy.

[79]  E. A. Tonna Periosteal Osteoclasts, Skeletal Development and Ageing , 1960, Nature.

[80]  W. R. Adey,et al.  Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R. Russell,et al.  An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.

[82]  S. Rodan,et al.  Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2. , 1981, Biochemical and biophysical research communications.

[83]  G. Striker,et al.  Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man , 1982, Nature.

[84]  M. Horton,et al.  Cell surface characterization of the human osteoclast: Phenotypic relationship to other bone marrow‐derived cell types , 1984, The Journal of pathology.

[85]  S. Sakamoto,et al.  Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue culture. A novel hypothesis for the mechanism of bone resorption. , 1982, Journal of periodontal research.

[86]  I. Brazell,et al.  The effect of parathyroid extract on cellular activity and plasma calcium levels in vivo. , 1969, The Journal of endocrinology.

[87]  S. Miller Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone , 1978, The Journal of cell biology.

[88]  J. Hock,et al.  DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones. , 1983, The Journal of clinical investigation.

[89]  S. Krane Heberden Oration 1980: aspects of the cell biology of the rheumatoid synovial lesion. , 1981, Annals of the rheumatic diseases.

[90]  R. Baron,et al.  Cellular kinetics of the bone remodeling sequence in the rat , 1982, The Anatomical record.

[91]  J. Loutit,et al.  The origin of osteoclasts. , 1982, Immunobiology.

[92]  H. Hanaoka,et al.  The origin of the osteoclast. , 1979, Clinical orthopaedics and related research.

[93]  D. Brenner,et al.  A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy , 1982, Cancer.

[94]  T. Chambers The cellular basis of bone resorption. , 1980, Clinical orthopaedics and related research.

[95]  W. Ryan,et al.  Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells. , 1976, Prostaglandins.

[96]  R. Luben,et al.  1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. , 1977, Science.

[97]  G. Rodan,et al.  Cyclic AMP and cyclic GMP: mediators of the mechanical effects on bone remodeling. , 1975, Science.

[98]  G. Vaes Cartilage and bone tissue damage in arthritis: cellular co-operation and enzymatic mechanisms. , 1981, Scandinavian journal of rheumatology. Supplement.

[99]  P. Revell,et al.  Resorption of bone by isolated rabbit osteoclasts. , 1984, Journal of cell science.

[100]  P. Gaillard Parathyroid gland and bone in vitro. VI , 1959 .

[101]  F. Dewhirst,et al.  Prostaglandin E2 levels and human periodontal disease. , 1974, Prostaglandins.

[102]  Chambers Tj The cellular basis of bone resorption. , 1980 .

[103]  J. I. Rader,et al.  Acute reduction in osteoclast number during bone repletion. , 1982, Metabolic bone disease & related research.

[104]  T. Martin,et al.  Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormones. , 1984, Biochemical and biophysical research communications.

[105]  D. Robinson,et al.  Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. , 1975, The Journal of clinical investigation.

[106]  Albert K. Harris,et al.  Fibroblast traction as a mechanism for collagen morphogenesis , 1981, Nature.

[107]  E. Jaffe,et al.  Hypercalcemia associated with T-cell lymphoma-leukemia. , 1981, American journal of clinical pathology.

[108]  H. DeLuca,et al.  Vitamin D is not directly necessary for bone growth and mineralization. , 1984, The American journal of physiology.

[109]  P. McSheehy,et al.  The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells , 1985, The Journal of pathology.

[110]  H P Koeffler,et al.  Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. , 1983, Blood.

[111]  J. Carter,et al.  Quantitative bone histology in the hypercalcemia of malignant disease. , 1982, The Journal of clinical endocrinology and metabolism.